181 related articles for article (PubMed ID: 10817792)
1. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.
Arkwright PD; Laurie S; Super M; Pravica V; Schwarz MJ; Webb AK; Hutchinson IV
Thorax; 2000 Jun; 55(6):459-62. PubMed ID: 10817792
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
[TBL] [Abstract][Full Text] [Related]
3. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.
Radtke T; Hebestreit H; Gallati S; Schneiderman JE; Braun J; Stevens D; Hulzebos EH; Takken T; Boas SR; Urquhart DS; Lands LC; Tejero S; Sovtic A; Dwyer T; Petrovic M; Harris RA; Karila C; Savi D; Usemann J; Mei-Zahav M; Hatziagorou E; Ratjen F; Kriemler S;
Ann Am Thorac Soc; 2018 Feb; 15(2):209-216. PubMed ID: 29140739
[TBL] [Abstract][Full Text] [Related]
4. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
5. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
Büscher R; Eilmes KJ; Grasemann H; Torres B; Knauer N; Sroka K; Insel PA; Ratjen F
Pharmacogenetics; 2002 Jul; 12(5):347-53. PubMed ID: 12142724
[TBL] [Abstract][Full Text] [Related]
6. The effect of TGF-β
Trojan T; Alejandre Alcazar MA; Fink G; Thomassen JC; Maessenhausen MV; Rietschel E; Schneider PM; van Koningsbruggen-Rietschel S
BMC Pulm Med; 2022 May; 22(1):183. PubMed ID: 35525938
[TBL] [Abstract][Full Text] [Related]
7. A cystic fibrosis mutation associated with mild lung disease.
Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of TGF-beta1 in cystic fibrosis patients.
Brazova J; Sismova K; Vavrova V; Bartosova J; Macek M; Lauschman H; Sediva A
Clin Immunol; 2006 Dec; 121(3):350-7. PubMed ID: 17052957
[TBL] [Abstract][Full Text] [Related]
11. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.
Arkwright PD; Pravica V; Geraghty PJ; Super M; Webb AK; Schwarz M; Hutchinson IV
Am J Respir Crit Care Med; 2003 Feb; 167(3):384-9. PubMed ID: 12554626
[TBL] [Abstract][Full Text] [Related]
12. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
Geborek A; Hjelte L
J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis genotype and assessing rates of decline in pulmonary status.
Cleveland RH; Zurakowski D; Slattery D; Colin AA
Radiology; 2009 Dec; 253(3):813-21. PubMed ID: 19952026
[TBL] [Abstract][Full Text] [Related]
14. Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.
Melotti P; Mafficini A; Lebecque P; Ortombina M; Leal T; Pintani E; Pepermans X; Sorio C; Assael BM
PLoS One; 2014; 9(12):e114274. PubMed ID: 25503271
[TBL] [Abstract][Full Text] [Related]
15. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.
Faria EJ; Faria IC; Ribeiro JD; Ribeiro AF; Hessel G; Bertuzzo CS
J Bras Pneumol; 2009 Apr; 35(4):334-42. PubMed ID: 19466271
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis.
El-Gamel A; Awad MR; Hasleton PS; Yonan NA; Hutchinson JA; Campbell CS; Rahman AH; Deiraniya AK; Sinnott PJ; Hutchinson IV
J Heart Lung Transplant; 1999 Jun; 18(6):517-23. PubMed ID: 10395349
[TBL] [Abstract][Full Text] [Related]
17. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.
Fajac I; Hubert D; Guillemot D; Honoré I; Bienvenu T; Volter F; Dall'Ava-Santucci J; Dusser DJ
Thorax; 2004 Nov; 59(11):971-6. PubMed ID: 15516474
[TBL] [Abstract][Full Text] [Related]
18. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.
Dahl M; Nordestgaard BG; Lange P; Tybjaerg-Hansen A
J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348
[TBL] [Abstract][Full Text] [Related]
19. Mild cystic fibrosis mutations in Southern Sweden with special reference to S549I and T338I.
Schaedel C; Andersson AM; Kristoffersson AC; Kornfält R; Lannefors L; Holmberg L
Clin Genet; 1998 May; 53(5):383-6. PubMed ID: 9660057
[TBL] [Abstract][Full Text] [Related]
20. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
